These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32004483)

  • 21. Prospective breast cancer risk prediction model for women undergoing screening mammography.
    Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
    J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
    Lawson MB; Bissell MCS; Miglioretti DL; Eavey J; Chapman CH; Mandelblatt JS; Onega T; Henderson LM; Rauscher GH; Kerlikowske K; Sprague BL; Bowles EJA; Gard CC; Parsian S; Lee CI
    JAMA Oncol; 2022 Aug; 8(8):1115-1126. PubMed ID: 35737381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.
    Wirtz HS; Boudreau DM; Gralow JR; Barlow WE; Gray S; Bowles EJ; Buist DS
    Breast Cancer Res Treat; 2014 Feb; 143(3):541-50. PubMed ID: 24407530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year risk of interval-invasive second breast cancer.
    Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.
    Hubbard RA; Zhu W; Horblyuk R; Karliner L; Sprague BL; Henderson L; Lee D; Onega T; Buist DS; Sweet A
    Breast Cancer Res Treat; 2013 Apr; 138(3):879-87. PubMed ID: 23471650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Screening Mammography to Detect Occult Malignancy in Autologous Breast Reconstructions: A 15-year Experience.
    Noroozian M; Carlson LW; Savage JL; Jeffries DO; Joe AI; Neal CH; Patterson SK; Hadjiiski LM; Helvie MA
    Radiology; 2018 Oct; 289(1):39-48. PubMed ID: 30129903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
    Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
    JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
    Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
    JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timeliness of follow-up after abnormal screening mammogram: variability of facilities.
    Rosenberg RD; Haneuse SJ; Geller BM; Buist DS; Miglioretti DL; Brenner RJ; Smith-Bindman R; Taplin SH;
    Radiology; 2011 Nov; 261(2):404-13. PubMed ID: 21900620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
    Sprague BL; Arao RF; Miglioretti DL; Henderson LM; Buist DS; Onega T; Rauscher GH; Lee JM; Tosteson AN; Kerlikowske K; Lehman CD;
    Radiology; 2017 Apr; 283(1):59-69. PubMed ID: 28244803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prioritizing Screening Mammograms for Immediate Interpretation and Diagnostic Evaluation on the Basis of Risk for Recall.
    Ho TH; Bissell MCS; Lee CI; Lee JM; Sprague BL; Tosteson ANA; Wernli KJ; Henderson LM; Kerlikowske K; Miglioretti DL
    J Am Coll Radiol; 2023 Mar; 20(3):299-310. PubMed ID: 36273501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Under utilization of surveillance mammography among older breast cancer survivors.
    Field TS; Doubeni C; Fox MP; Buist DS; Wei F; Geiger AM; Quinn VP; Lash TL; Prout MN; Yood MU; Frost FJ; Silliman RA
    J Gen Intern Med; 2008 Feb; 23(2):158-63. PubMed ID: 18060463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk-Based Screening Mammography for Women Aged <40: Outcomes From the National Mammography Database.
    Lee CS; Ashih H; Sengupta D; Sickles EA; Zuley M; Pisano E
    J Am Coll Radiol; 2020 Mar; 17(3):368-376. PubMed ID: 31541655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.
    Goldman LE; Walker R; Hubbard R; Kerlikowske K;
    Med Care; 2013 Apr; 51(4):307-14. PubMed ID: 23358386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
    Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
    Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography facility characteristics associated with interpretive accuracy of screening mammography.
    Taplin S; Abraham L; Barlow WE; Fenton JJ; Berns EA; Carney PA; Cutter GR; Sickles EA; Carl D; Elmore JG
    J Natl Cancer Inst; 2008 Jun; 100(12):876-87. PubMed ID: 18544742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
    Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
    AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer.
    Kim GR; Cho N; Kim SY; Han W; Moon WK
    Radiology; 2021 Aug; 300(2):314-323. PubMed ID: 34100684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.